Truist Securities Maintains Buy on American Healthcare REIT, Raises Price Target to $61
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Truist Securities analyst Michael Lewis maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $57 to $61.
Truist Securities analyst Michael Lewis maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $57 to $61.